About: Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, which is in Phase 3 confirmatory trial for the treatment of negative symptoms in patients with schizophrenia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $4.12 (-5.72%)
NERVNASDAQMinerva Neurosciences Inc
Minerva Neurosciences Inc share price
NERV price activity
Last Price
$4.140
Change (24hr)
-0.23 USD (-5.26%)
Volume
92.43K
Volume (4w avg)
-
Open
$4.35
Day Range
$4.10 - $4.43
Previous Close
$4.37
Last Trade
09 Sep, 8:00 pm GMT+0
Delayed
09 Sep, 8:00 pm GMT+0
NERV price performance
Delayed
09 Sep, 8:00 pm GMT+0
NERV Market Signals